Cempra to Present at Three Upcoming Investor Conferences
September 03, 2015 07:30 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present at the Wedbush PacGrow 2015 Healthcare Conference
August 04, 2015 07:30 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Reports Second Quarter 2015 Financial Results and Provides Corporate Update
July 29, 2015 16:04 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., July 29, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Report Second Quarter 2015 Financial Results
July 22, 2015 07:30 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., July 22, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Completes Patient Enrollment of Solitaire-IV Phase 3 Clinical Trial
July 07, 2015 07:00 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., July 7, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present at the Jefferies 2015 Global Healthcare Conference
May 26, 2015 07:30 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., May 26, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Presenting Additional Data From the Phase 3 Oral Solithromycin Study in Community Acquired Bacterial Pneumonia at the American Thoracic Society Conference
May 19, 2015 07:00 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., May 19, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present Solithromycin Data at Two Upcoming Medical Conferences
May 12, 2015 07:30 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., May 12, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Reports First Quarter 2015 Financial Results and Provides Corporate Update
April 30, 2015 16:04 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., April 30, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Report First Quarter 2015 Financial Results
April 23, 2015 07:30 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., April 23, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...